Assignee
ARTIVA BIOTHERAPEUTICS INC
US·0 granted patents·10 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
10 records- 0159US2026048084A1Methods of administering natural killer cells comprising an anti-human epidermal growth factor receptor 2 (her2) chimeric antigen receptor (car)ARTIVA BIOTHERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0258US2024424099A1Treatment of cancer with nk cells and multispecific engagersARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0353US2025073264A1Chimeric antigen receptor comprising an anti-her2 antibody or antigen-binding fragment thereof and natural killer cells comprising the sameARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0452US2024180962A1Treatment of cancer with nk cells and a cd20 targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0550US2024366663A1Chimeric antigen receptor comprising an anti-cd19 antibody or antigen-binding fragment thereof and natural killer cells comprising the sameARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0648US2024366664A1Treatment of cancer with nk cells and an egfr targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0748US2024197778A1Treatment of cancer with nk cells and a her2 targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0847US2024115704A1Treatment of cancer with nk cells and a cd38-targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0947US2024000840A1Treatment of cancer with nk cells and a cd20 targeted antibodyARTIVA BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1047US2024060046A1Expanded and stimulated natural killer cellsARTIVA BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ARTIVA BIOTHERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →